Yayıncı "The Texas Heart Institute" Tıp Fakültesi için listeleme
Toplam kayıt 1, listelenen: 1-1
-
Do Patients With Arterial Occlusive Disease of Different Etiologies Benefit Equally From Cilostazol?
(The Texas Heart Institute, 2023)Background: Cilostazol is a guideline-recommended drug that improves intermittent claudication and quality of life in patients with chronic atherosclerotic peripheral arterial disease. The drug is used for most etiologies ...